Keywords
Anxiety
5-HT6
Lateral Habenula
6-Hydroxydopamine
Submitted : 2025-07-05
Accepted : 2025-07-20
Published : 2025-08-04
Abstract
Objectives: Anxiety represents one of the most frequently observed non-motor manifestations in patients diagnosed with Parkinson’s disease (PD), yet its neurobiological mechanisms remain largely unclear. The lateral habenular nucleus (LHb), an essential part of the limbic-monoaminergic system, plays a vital role in emotional regulation and houses serotonin 5-HT6 receptors, which are considered promising candidates for anxiolytic therapies. This research aimed to clarify the role of LHb 5-HT6 receptors in modulating anxiety-like behaviors within Parkinsonian contexts. Methods: To model PD, rats underwent unilateral 6-hydroxydopamine (6-OHDA) lesions targeting the medial forebrain bundle (MFB), while control animals received sham operations. Anxiety-related responses were examined utilizing the open field test (OFT) and elevated plus maze (EPM). Pharmacological modulation of LHb 5-HT6 receptors was achieved via microinjection of either the agonist WAY208466 or the antagonist SB258585. To account for potential locomotor confounds, spontaneous locomotor activity was measured. Results: Animals subjected to MFB lesions exhibited pronounced anxiety-related behaviors. This was evidenced by a reduction in center zone occupancy in the OFT, along with fewer entries into and less time spent within the open arms of the EPM. In the sham-operated rats, administering WAY208466 into the LHb induced anxiety-like behaviors, whereas SB258585 exhibited anxiolytic effects. Interestingly, lesioned rats responded to WAY208466 with anxiolytic effects, while SB258585 elicited anxiety-like behaviors. Notably, both compounds showed efficacy at lower doses among the lesioned rats compared to the sham controls. These behavioral changes occurred without notable alterations in locomotor activity. Conclusion: This study demonstrates that 5-HT6 receptors in the LHb exert bidirectional modulatory effects on anxiety-like behavior. In the PD model, the pharmacological actions of 5-HT6 receptor agents diverged from those observed in intact animals, suggesting that PD pathology may alter LHb 5-HT6 receptor function or sensitivity. These findings indicate that LHb 5-HT6 receptors may represent a promising therapeutic target for managing anxiety symptoms in PD.
References
Michel L, Molina P, Mameli M, 2024, The Behavioral Relevance of a Modular Organization in the Lateral Habenula. Neuron, 112(16): 2669–2685.
Ables JL, Park K, Ibañez-Tallon I, 2023, Understanding the Habenula: A Major Node in Circuits Regulating Emotion and Motivation. Pharmacol Res, 190: 106734.
Samanci B, Tan S, Michielse S, et al, 2024, The Habenula in Parkinson's Disease: Anatomy, Function, and Implications for Mood Disorders – A Narrative Review. J Chem Neuroanat, 136: 102392.
Chagraoui A, Thibaut F, De Deurwaerdère P, 2025, 5-HT6 Receptors: Contemporary Views on Their Neurobiological and Pharmacological Relevance in Neuropsychiatric Disorders. Dialogues Clin Neurosci, 27(1): 112–128.
Zhang YM, Guo Y, Du CX, et al., 2018, Serotonin₆ Receptors in the Prelimbic Cortex Are Involved in the Regulation of Anxiety-Like Behaviors in the Rat 6-Hydroxydopamine Parkinson’s Disease Model. Chin J Physiol, 61(4): 201–209.
Osacka J, Kiss A, Pirnik Z, 2022, Possible Involvement of Apoptosis in the Antipsychotics Side Effects: A Mini-Review. Clin Exp Pharmacol Physiol, 49(8): 836–847.
Weintraub D, Aarsland D, Chaudhuri KR, et al., 2022, The Neuropsychiatry of Parkinson's Disease: Advances and Challenges. Lancet Neurol, 21(1): 89–102.
Ling XZ, Yuan XZ, Luo X, et al., 2023, An Update on Nondopaminergic Treatments for Motor and Non-Motor Symptoms of Parkinson's Disease. Curr Neuropharmacol, 21(8): 1806–1826.
Tang G, Guo Y, Li R, et al., 2024, Lateral Habenula 5-HT1B Receptors Are Involved in Regulation of Anxiety-Like Behaviors in Parkinsonian Rats. Neurochem Int, 177: 105766.
Paxinos G, Watson C, 1998, The Rat Brain in Stereotaxic Coordinates. New York: Academic Press, United States of America.
Çevik ÖS, Yıldırım DD, Uzun C, et al., 2025, Contribution of Distinctive Outcome Measures to the Assessment of Anxiety in the Open Field: A Meta-Analysis of Factors Mediating Open-Field Test Variability in Rodent Models of Anxiety. Behav Brain Res, 490: 115612.
Coimbra NC, Paschoalin-Maurin T, Bassi GS, et al., 2017, Critical Neuropsychobiological Analysis of Panic Attack- and Anticipatory Anxiety-Like Behaviors in Rodents Confronted with Snakes in Polygonal Arenas and Complex Labyrinths. Braz J Psychiatry, 39(1): 72–83.
Chen L, Lu Y, Hua X, et al., 2024, Three Methods of Behavioural Testing to Measure Anxiety – A Review. Behav Processes, 215: 104997.
Hui YP, Zhang QJ, Zhang L, et al., 2014, Activation of Prelimbic 5-HT1A Receptors Produces Antidepressant-Like Effects in a Unilateral Rat Model of Parkinson's Disease. Neuroscience, 268: 265–275.
Braverman AM, Davoudian T, Levin IK, et al., 2024, Depression, Anxiety, Quality of Life, and Infertility: A Global Lens on the Last Decade of Research. Fertil Steril, 121(3): 379–383.
Higashino K, Ago Y, Umehara M, et al., 2014, Effects of Acute and Chronic Administration of Venlafaxine and Desipramine on Extracellular Monoamine Levels in the Mouse Prefrontal Cortex and Striatum. Eur J Pharmacol, 729: 86–93.
Delaville C, Chetrit J, Abdallah K, et al., 2012, Emerging Dysfunctions Consequent to Combined Monoaminergic Depletions in Parkinsonism. Neurobiol Dis, 45(2): 763–773.
Hui YP, Wang T, Han LN, et al., 2015, Anxiolytic Effects of Prelimbic 5-HT(1A) Receptor Activation in the Hemiparkinsonian Rat. Behav Brain Res, 277: 211–220.
Piper JA, Musumeci G, Castorina A, 2024, The Neuroanatomy of the Habenular Complex and Its Role in the Regulation of Affective Behaviors. J Funct Morphol Kinesiol, 9(1): 14.
Wesołowska A, Rychtyk J, Gdula-Argasińska J, et al., 2021, Effect of 5-HT6 Receptor Ligands Combined with Haloperidol or Risperidone on Antidepressant-/Anxiolytic-Like Behavior and BDNF Regulation in Hippocampus and Prefrontal Cortex of Rats. Neuropsychiatr Dis Treat, 17: 2105–2127.
Wesolowska A, Nikiforuk A, Stachowicz K, 2007, Anxiolytic-Like and Antidepressant-Like Effects Produced by the Selective 5-HT6 Receptor Antagonist SB258585 After Intrahippocampal Administration to Rats. Behav Pharmacol, 18(5–6): 439–446.
Hirano K, Piers TM, Searle KL, et al., 2009, Procognitive 5-HT6 Antagonists in the Rat Forced Swimming Test: Potential Therapeutic Utility in Mood Disorders Associated with Alzheimer's Disease. Life Sci, 84(15–16): 558–562.
Wesolowska A, 2008, The Anxiolytic-Like Effect of the Selective 5-HT6 Receptor Antagonist SB-399885: The Impact of Benzodiazepine Receptors. Eur J Pharmacol, 580(3): 355–360.
Rosse G, Schaffhauser H, 2010, 5-HT6 Receptor Antagonists as Potential Therapeutics for Cognitive Impairment. Curr Top Med Chem, 10(2): 207–221.
Mlost J, Białoń M, Kędziora M, et al., 2024, Network Analysis of Monoamines Involved in Anxiety-Like Behavior in a Rat Model of Osteoarthritis. Pharmacol Rep, 76(1): 72–85.
Masuda T, Nishikawa H, Inoue T, et al., 2013, 5-HT Depletion, but Not 5-HT1A Antagonist, Prevents the Anxiolytic-Like Effect of Citalopram in Rat Contextual Conditioned Fear Stress Model. Acta Neuropsychiatr, 25(2): 77–84.
Grahn RE, Watkins LR, Maier SF, 2000, Impaired Escape Performance and Enhanced Conditioned Fear in Rats Following Exposure to an Uncontrollable Stressor Are Mediated by Glutamate and Nitric Oxide in the Dorsal Raphe Nucleus. Behav Brain Res, 112(1–2): 33–41.
Poller WC, Bernard R, Derst C, et al., 2011, Lateral Habenular Neurons Projecting to Reward-Processing Monoaminergic Nuclei Express Hyperpolarization-Activated Cyclic Nucleotid-Gated Cation Channels. Neuroscience, 193: 205–216.
Liu KC, Li JY, Tan HH, et al., 2015, Serotonin₆ Receptors in the Dorsal Hippocampus Regulate Depressive-Like Behaviors in Unilateral 6-Hydroxydopamine-Lesioned Parkinson's Rats. Neuropharmacology, 95: 290–298.